PL377533A1 - Kompleksy E-2-metoksy-N-(3-{4-[3-metylo-4-(6-metylopirydyn-3-yloksy)-fenyloamino]-chinazolin-6-ylo}-allilo)-acetamidu, sposób ich wytwarzania i zastosowanie - Google Patents

Kompleksy E-2-metoksy-N-(3-{4-[3-metylo-4-(6-metylopirydyn-3-yloksy)-fenyloamino]-chinazolin-6-ylo}-allilo)-acetamidu, sposób ich wytwarzania i zastosowanie

Info

Publication number
PL377533A1
PL377533A1 PL377533A PL37753303A PL377533A1 PL 377533 A1 PL377533 A1 PL 377533A1 PL 377533 A PL377533 A PL 377533A PL 37753303 A PL37753303 A PL 37753303A PL 377533 A1 PL377533 A1 PL 377533A1
Authority
PL
Poland
Prior art keywords
methyl
quinazolin
phenylamino
yloxy
pyridin
Prior art date
Application number
PL377533A
Other languages
English (en)
Inventor
Zheng Jane Li
Jason Albert Leonard
Andrew Vincent Trask
John Charles Kath
Daniel Tyler Richter
Carl Brian Thompson
Joel Morris
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of PL377533A1 publication Critical patent/PL377533A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL377533A 2002-12-19 2003-12-08 Kompleksy E-2-metoksy-N-(3-{4-[3-metylo-4-(6-metylopirydyn-3-yloksy)-fenyloamino]-chinazolin-6-ylo}-allilo)-acetamidu, sposób ich wytwarzania i zastosowanie PL377533A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US43470002P 2002-12-19 2002-12-19

Publications (1)

Publication Number Publication Date
PL377533A1 true PL377533A1 (pl) 2006-02-06

Family

ID=32682089

Family Applications (1)

Application Number Title Priority Date Filing Date
PL377533A PL377533A1 (pl) 2002-12-19 2003-12-08 Kompleksy E-2-metoksy-N-(3-{4-[3-metylo-4-(6-metylopirydyn-3-yloksy)-fenyloamino]-chinazolin-6-ylo}-allilo)-acetamidu, sposób ich wytwarzania i zastosowanie

Country Status (21)

Country Link
US (1) US20050075354A1 (pl)
EP (1) EP1575936A1 (pl)
JP (1) JP2006512355A (pl)
KR (1) KR20050085835A (pl)
CN (1) CN1726208A (pl)
AR (1) AR042508A1 (pl)
AU (1) AU2003283743A1 (pl)
BR (1) BR0317259A (pl)
CA (1) CA2509140A1 (pl)
GT (1) GT200300287A (pl)
MX (1) MXPA05006582A (pl)
NL (1) NL1025072C2 (pl)
NO (1) NO20052803L (pl)
PA (1) PA8592501A1 (pl)
PE (1) PE20040915A1 (pl)
PL (1) PL377533A1 (pl)
RU (1) RU2005122659A (pl)
TW (1) TW200424191A (pl)
UY (1) UY28129A1 (pl)
WO (1) WO2004056802A1 (pl)
ZA (1) ZA200504621B (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050192298A1 (en) * 2004-02-27 2005-09-01 Pfizer Inc Crystal forms of E-2-Methoxy-N-(3-{4-[3-methyl-4-(6-methyl-pyridin-3-yloxy)-phenylamino]-quinazolin-6-yl}-allyl)-acetamide
JP2008542356A (ja) * 2005-06-03 2008-11-27 ファイザー・プロダクツ・インク 異常な細胞増殖の治療用の二環式誘導体
EP4166558A1 (en) † 2010-02-12 2023-04-19 Pfizer Inc. Salts and polymorphs of 8-fluoro-2-{4- [(methylamino)methyl]phenyl}-1 ,3,4,5-tetrahydro-6h-azepino[5,4,3- cd]indol-6-one
US8628554B2 (en) 2010-06-13 2014-01-14 Virender K. Sharma Intragastric device for treating obesity
US9526648B2 (en) 2010-06-13 2016-12-27 Synerz Medical, Inc. Intragastric device for treating obesity
US10010439B2 (en) 2010-06-13 2018-07-03 Synerz Medical, Inc. Intragastric device for treating obesity
US10420665B2 (en) 2010-06-13 2019-09-24 W. L. Gore & Associates, Inc. Intragastric device for treating obesity
US10779980B2 (en) 2016-04-27 2020-09-22 Synerz Medical, Inc. Intragastric device for treating obesity

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6884418B1 (en) * 1989-08-04 2005-04-26 Berlex Laboratories, Inc. Use of ligand-mimicking agents and anti-neoplastic drugs in cancer therapy
EP1292591B1 (en) * 2000-06-22 2005-02-02 Pfizer Products Inc. Substituted bicyclic derivatives for the treatment of abnormal cell growth
IL160971A0 (en) * 2001-11-30 2004-08-31 Pfizer Prod Inc Processes for the preparation of substituted bicyclic derivatives for the treatment of abnormal cell growth
AP2004003058A0 (en) * 2001-12-12 2004-06-30 Pfizer Prod Inc Quinazoline derivatives for the treatment of abnormal cell growth.
PL370858A1 (pl) * 2001-12-12 2005-05-30 Pfizer Products Inc. Postacie soli E-2-metoksy-N-(3-{4-[3-metylo-4-(6-metylo-pirydyn-3-yloksy) fenyloamino] chinazolin-6-ylo} allilo)-acetamidu, ich wytwarzanie i ich zastosowanie przeciwrakowe

Also Published As

Publication number Publication date
AR042508A1 (es) 2005-06-22
RU2005122659A (ru) 2006-01-20
US20050075354A1 (en) 2005-04-07
PE20040915A1 (es) 2005-01-18
TW200424191A (en) 2004-11-16
EP1575936A1 (en) 2005-09-21
KR20050085835A (ko) 2005-08-29
WO2004056802A1 (en) 2004-07-08
UY28129A1 (es) 2004-07-30
NL1025072A1 (nl) 2004-06-22
CA2509140A1 (en) 2004-07-08
BR0317259A (pt) 2005-11-08
ZA200504621B (en) 2006-03-29
GT200300287A (es) 2004-11-30
PA8592501A1 (es) 2004-09-16
JP2006512355A (ja) 2006-04-13
CN1726208A (zh) 2006-01-25
NL1025072C2 (nl) 2007-07-24
NO20052803D0 (no) 2005-06-09
NO20052803L (no) 2005-09-16
AU2003283743A1 (en) 2004-07-14
MXPA05006582A (es) 2005-08-16

Similar Documents

Publication Publication Date Title
PL370858A1 (pl) Postacie soli E-2-metoksy-N-(3-{4-[3-metylo-4-(6-metylo-pirydyn-3-yloksy) fenyloamino] chinazolin-6-ylo} allilo)-acetamidu, ich wytwarzanie i ich zastosowanie przeciwrakowe
AU2003270785A1 (en) Process for preparing quinazoline rho-kinase inhibitors and intermediates thereof
ATE376357T1 (de) Chinolin-; isochinolin- und chinazolinoxyalkylamide und ihre verwendung als fungizide
PL375390A1 (pl) 4-Trifluormetylopirazolilo-podstawione pirydyny ipirymidyny
ATE340300T1 (de) Brandschutztür und ihr herstellungsverfahren
IL164167A0 (en) 4-(N-phenylamino)-quinazolines/ quinolines as tyrosine kinase inhibitors
AU2003290973A8 (en) Coating reinforcing underlayment and method of manufacturing same
NL300784I2 (nl) Ketorolac, of het trometamolzout ervan, en fenylefrine, of het hydrochloridezout ervan
NO20035055D0 (no) Substituerte pyrazinoner, pyridiner og pyrimidiner som corticotropin leverende faktor ligander
EP1529367A4 (en) METHOD FOR SAFELY RECEIVING AND SAFEGUARDING PERSON-BONDED IDENTITY PROCESSING IN ELECTRONIC DEVICES
EP1488316A4 (en) SYSTEMS AND METHOD FOR IMPROVING SAFETY OF ELECTRONIC COMMUNICATION
DE60319662D1 (de) Piezoelektrischer Oszillator, dessen Herstellungsverfahren und elektronisches Bauteil
ZA200501381B (en) New spirocondensed quinazolinones and their use as phosphodiesterase inhibitors
DE60333066D1 (de) Triterpenoid-haltige Submicronliposomen und ihre Herstellungsweise
SG2009082793A (en) Biaryl heterocyclic compounds and methods of making and using the same
GB0309014D0 (en) Zero drill completion and production system
AU2003301662A1 (en) Quinazolinones and derivatives thereof as factor xa inhibitors
AU2003223789A8 (en) Constraint-based production planning and scheduling
DE60329910D1 (de) Substituierte benzazole und ihre verwendung als raf-kinase-hemmer
DE60208661D1 (de) Diaminothiazole und ihre verwendung als cyclinabhängige kinase inhibitoren
DE60206957D1 (de) Vliesstoff und herstellungsverfahren
DE50313157D1 (de) Phenylaminopyrimidine und ihre verwendung als rho-kinase inhibitoren
DE60325403D1 (de) Vliesstoff aus kernmantelfaser und verfahren zu dessen herstellung
PL377533A1 (pl) Kompleksy E-2-metoksy-N-(3-{4-[3-metylo-4-(6-metylopirydyn-3-yloksy)-fenyloamino]-chinazolin-6-ylo}-allilo)-acetamidu, sposób ich wytwarzania i zastosowanie
DE60211082D1 (de) Toner und Tonerherstellungsverfahren

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)